Alumni Stories

C. Richard Schlegel, M.D., Ph.D.

Academic Chair and Professor, Department of Pathology
Georgetown University

Location: Wagner Alumni House
Interviewer/Producer: Anneliesa Clump Alprin (G’06)
Editor: Lisa Fthenakis (C’10) C. Richard Schlegel

Dr. Richard Schlegel’s Georgetown laboratory developed the technology for the human papillomavirus (HPV) vaccine, patented in 2005. The U.S. Food and Drug Administration approved the HPV vaccine for use in June 2006. Here, Schlegel shares the story of discovering the first vaccine for cervical cancer and describes his work with the Bill and Melinda Gates Foundation and the National Institutes of Health (NIH) to develop second- and third-generation vaccines for use in the developing world.

In 1980, Schlegel was an investigator at the National Cancer Institute (NCI), after which he served as senior investigator and, later, chief of the Cell Regulation and Transformation Section in the Laboratory of Tumor Virus Biology at NCI. In 1990, he joined the Georgetown University Medical Center as an associate professor in the Department of Pathology, and became department chair in 2003. He serves on the editorial board of Virology and is a permanent member of the NIH Virology Study Section. He received his M.D. and Ph.D. from Northwestern University Medical School and was a resident and post-doctoral fellow at Harvard Medical School’s Brigham and Women’s Hospital in the fields of pathology and virology.

Additional Resources

ScienceDaily
“Georgetown Research Leads To First Cancer Vaccine”
June 9, 2006
http://www.sciencedaily.com/releases/2006/06/060608225351.htm

The Washington Post
“HPV Vaccine”
Jan. 17, 2007
http://www.washingtonpost.com/wp-dyn/content/discussion/2007/01/16/DI2007011600929.html

Georgetown University
Office of the President
“Investiture of Dr. Richard Schlegel as Oscar B. Hunter Chair of Pathology”
Dec. 14, 2009
http://president.georgetown.edu/sections/speeches/85647.html

Share a Comment